Daniel A. Monti, MD

Contact Dr. Monti

925 Chestnut Street
Suite 120
Philadelphia, PA 19107

(215) 955-2221
(215) 955-2509 fax

Most Recent Peer-reviewed Publications

  1. Effect of a one-week spiritual retreat on dopamine and serotonin transporter binding: a preliminary study
  2. Changes in cerebellar functional connectivity and autonomic regulation in cancer patients treated with the Neuro Emotional Technique for traumatic stress symptoms
  3. Costs and effectiveness of mindfulness- based art therapy versus standard breast cancer support group for women with cancer
  4. Neuro emotional technique effects on brain physiology in cancer patients with traumatic stress symptoms: preliminary findings
  5. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer
  6. Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity
  7. N-Acetyl cysteine may support dopamine neurons in Parkinson's disease: Preliminary clinical and cell line data
  8. Complementary mind-body therapies in cancer
  9. Current evidence regarding the management of mood and anxiety disorders using complementary and alternative medicine
  10. Meditation and neurodegenerative diseases
  11. Diet and nutrition in cancer survivorship and palliative care
  12. Working memory and meditation
  13. Psychosocial benefits of a novel mindfulness intervention versus standard support in distressed women with breast cancer
  14. Selectively starving cancer cells through dietary manipulation: Methods and clinical implications
  15. The BraveNet prospective observational study on integrative medicine treatment approaches for pain
  16. Complementary mind–body therapies in cancer
  17. Changes in cerebral blood flow and anxiety associated with an 8-week mindfulness programme in women with breast cancer
  18. Patients seek integrative medicine for preventive approach to optimize health
  19. Positron emission tomography in neurological and psychiatric disorders
  20. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer